Multiple Sclerosis Journal - October 2017 - 1471
G Datta, IR Violante et al.
survey image was used to identify the anterior commissure (AC) and posterior commissure (PC). The
spectroscopy voxel was positioned just superior to the
lateral ventricles in the midline. The spectroscopy
voxel measured 40 mm anteroposterior × 25 mm
craniocaudal × 40 mm left-right. The voxel was
selected based on recommendations for use of MR
spectroscopy in MS patients, with modification of
length to accommodate the overall volume in our full
population.15
Proton spectra were acquired using a PRESS (Point
Resolved Spectroscopy) sequence (repetition
time = 2000 ms, echo time = 30 ms, 96 averages, 1024
data points). Magnetic field homogeneity was optimised to a linewidth of ~5 Hz over the spectroscopy
voxel using the proton signal from water. Water suppression was achieved by a chemically selective saturation, the WET (water suppression enhanced through
T1 effects) method.16
MRS analyses
LCModel software (version 6.3) was used for metabolite quantification applying the internal water reference method, accounting for different water content
in grey matter, white matter and cerebrospinal
fluid.17 LCModel analyses the magnetic resonance
spectrum as a linear combination of the basis set of
complete model spectra of metabolites from a normal population library.17 Only metabolites with
Cramér-Rao bounds <20% were considered.
Concentrations of NAA, myo-inositol, glycerophosphocholine and creatine plus phosphocreatine were
used in this study. Concentrations in millimole
(mM) units were calculated for all metabolites by
the software. Patient and MRI system factors (such
as radiofrequency receiver properties affected by
variability of gain in the amplifiers of the receiver
system, head size and position) can influence the
resonance intensity in ways the analytical algorithm
cannot account for. Our analysis used 'un-corrected'
concentrations only for the same brain and the same
scan session, when normalisation values for metabolite concentrations are identical. Otherwise, we
used internal normalisations of metabolite concentration. Creatine and phosphocreatine are present in
both neurons and glia. Their summed concentration,
referred to as total creatine concentration, shows little or no change in chronic lesions or normalappearing white matter (NAWM) in MS.18 Total
creatine concentration therefore was used as the
'internal standard' for normalisation of signals from
other metabolites from the same voxel.
journals.sagepub.com/home/msj
PET scanning
PET scanning (Discovery RX PET/CT scanner) was
performed with a trans-axial resolution of 5.0 mm and
a radial resolution of 5.1 mm at 1 cm from the centre
of the FOV in 3D mode. [11C]PBR28 was injected as
an intravenous bolus over approximately 20 seconds
at the start of a 90 minutes dynamic PET acquisition.
Injected activities for [11C]PBR28 ranged from 223.8
to 379.6 MBq (325.6 ± 34.6 MBq, n = 44). Injected
mass for different subjects ranged from 1.16 to 8.91 µg
(2.75 ± 1.64 µg). PET data were reconstructed using
filtered back projection, including corrections for
attenuation and scatter (based on a low-dose CT
acquisition). The dynamic data were binned into 26
frames (durations: 8 × 15 seconds, 3 × 1 minutes,
5 × 2 minutes, 5 × 5 minutes, 5 × 10 minutes).
Radioligand synthesis
Radiosynthesis and quality control were performed
on-site, as previously described, obtaining radiochemical purities of >95%.11
[11C]PBR28 PET image and kinetic analysis
T2 FLAIR images were rigidly registered to T1 using
FLIRT (FMRIB Software Library v5.0). WMLs were
manually segmented on the registered T2 image using
Jim software (Xinapse Systems v7). The WML mask
was used for lesion-filling the T1 image before segmentation into white matter, grey matter and cerebrospinal fluid using the FSL (FMRIB Software Library
v5.0) tools FAST and FIRST.19 Normalised brain volumes were calculated using SIENAX (FMRIB
Software Library v5.0).19 A mask of NAWM was created by subtracting the WML mask dilated by 6 mm
around its edges in 3D and the resulting mask further
eroded by 3 mm. The masks of WML, NAWM and
grey matter were multiplied by the mask of the spectroscopy voxel to create the respective masks within
the spectroscopy voxel.
The T1 image and dynamic PET images were used as
inputs for the MIAKAT (Molecular Imaging and
Kinetic Analysis Toolbox) software package (www.
miakat.org) for kinetic analysis of PET data. For this,
PET images were motion corrected using a frame-byframe realignment algorithm, in which all frames
were individually realigned to a reference frame and
rigid registered to the MNI (Montreal Neurological
Institute) space using SPM5 (Wellcome Trust Centre
for Neuroimaging, http://www.fil.ion.ucl.ac.uk/spm).
These transformed four-dimensional (4D) PET
images were integrated over time to obtain 3D PET
1471
http://www.miakat.org
http://www.miakat.org
http://www.fil.ion.ucl.ac.uk/spm
https://journals.sagepub.com/home/msj
Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017
Contents
Multiple Sclerosis Journal - October 2017 - Cover1
Multiple Sclerosis Journal - October 2017 - Cover2
Multiple Sclerosis Journal - October 2017 - Contents
Multiple Sclerosis Journal - October 2017 - ii
Multiple Sclerosis Journal - October 2017 - iii
Multiple Sclerosis Journal - October 2017 - 1436
Multiple Sclerosis Journal - October 2017 - 1437
Multiple Sclerosis Journal - October 2017 - 1438
Multiple Sclerosis Journal - October 2017 - 1439
Multiple Sclerosis Journal - October 2017 - 1440
Multiple Sclerosis Journal - October 2017 - 1441
Multiple Sclerosis Journal - October 2017 - 1442
Multiple Sclerosis Journal - October 2017 - 1443
Multiple Sclerosis Journal - October 2017 - 1444
Multiple Sclerosis Journal - October 2017 - 1445
Multiple Sclerosis Journal - October 2017 - 1446
Multiple Sclerosis Journal - October 2017 - 1447
Multiple Sclerosis Journal - October 2017 - 1448
Multiple Sclerosis Journal - October 2017 - 1449
Multiple Sclerosis Journal - October 2017 - 1450
Multiple Sclerosis Journal - October 2017 - 1451
Multiple Sclerosis Journal - October 2017 - 1452
Multiple Sclerosis Journal - October 2017 - 1453
Multiple Sclerosis Journal - October 2017 - 1454
Multiple Sclerosis Journal - October 2017 - 1455
Multiple Sclerosis Journal - October 2017 - 1456
Multiple Sclerosis Journal - October 2017 - 1457
Multiple Sclerosis Journal - October 2017 - 1458
Multiple Sclerosis Journal - October 2017 - 1459
Multiple Sclerosis Journal - October 2017 - 1460
Multiple Sclerosis Journal - October 2017 - 1461
Multiple Sclerosis Journal - October 2017 - 1462
Multiple Sclerosis Journal - October 2017 - 1463
Multiple Sclerosis Journal - October 2017 - 1464
Multiple Sclerosis Journal - October 2017 - 1465
Multiple Sclerosis Journal - October 2017 - 1466
Multiple Sclerosis Journal - October 2017 - 1467
Multiple Sclerosis Journal - October 2017 - 1468
Multiple Sclerosis Journal - October 2017 - 1469
Multiple Sclerosis Journal - October 2017 - 1470
Multiple Sclerosis Journal - October 2017 - 1471
Multiple Sclerosis Journal - October 2017 - 1472
Multiple Sclerosis Journal - October 2017 - 1473
Multiple Sclerosis Journal - October 2017 - 1474
Multiple Sclerosis Journal - October 2017 - 1475
Multiple Sclerosis Journal - October 2017 - 1476
Multiple Sclerosis Journal - October 2017 - 1477
Multiple Sclerosis Journal - October 2017 - 1478
Multiple Sclerosis Journal - October 2017 - 1479
Multiple Sclerosis Journal - October 2017 - 1480
Multiple Sclerosis Journal - October 2017 - 1481
Multiple Sclerosis Journal - October 2017 - 1482
Multiple Sclerosis Journal - October 2017 - 1483
Multiple Sclerosis Journal - October 2017 - 1484
Multiple Sclerosis Journal - October 2017 - 1485
Multiple Sclerosis Journal - October 2017 - 1486
Multiple Sclerosis Journal - October 2017 - 1487
Multiple Sclerosis Journal - October 2017 - 1488
Multiple Sclerosis Journal - October 2017 - 1489
Multiple Sclerosis Journal - October 2017 - 1490
Multiple Sclerosis Journal - October 2017 - 1491
Multiple Sclerosis Journal - October 2017 - 1492
Multiple Sclerosis Journal - October 2017 - 1493
Multiple Sclerosis Journal - October 2017 - 1494
Multiple Sclerosis Journal - October 2017 - 1495
Multiple Sclerosis Journal - October 2017 - 1496
Multiple Sclerosis Journal - October 2017 - 1497
Multiple Sclerosis Journal - October 2017 - 1498
Multiple Sclerosis Journal - October 2017 - 1499
Multiple Sclerosis Journal - October 2017 - 1500
Multiple Sclerosis Journal - October 2017 - 1501
Multiple Sclerosis Journal - October 2017 - 1502
Multiple Sclerosis Journal - October 2017 - 1503
Multiple Sclerosis Journal - October 2017 - 1504
Multiple Sclerosis Journal - October 2017 - 1505
Multiple Sclerosis Journal - October 2017 - 1506
Multiple Sclerosis Journal - October 2017 - 1507
Multiple Sclerosis Journal - October 2017 - 1508
Multiple Sclerosis Journal - October 2017 - 1509
Multiple Sclerosis Journal - October 2017 - 1510
Multiple Sclerosis Journal - October 2017 - 1511
Multiple Sclerosis Journal - October 2017 - 1512
Multiple Sclerosis Journal - October 2017 - 1513
Multiple Sclerosis Journal - October 2017 - 1514
Multiple Sclerosis Journal - October 2017 - 1515
Multiple Sclerosis Journal - October 2017 - 1516
Multiple Sclerosis Journal - October 2017 - 1517
Multiple Sclerosis Journal - October 2017 - 1518
Multiple Sclerosis Journal - October 2017 - 1519
Multiple Sclerosis Journal - October 2017 - 1520
Multiple Sclerosis Journal - October 2017 - 1521
Multiple Sclerosis Journal - October 2017 - 1522
Multiple Sclerosis Journal - October 2017 - 1523
Multiple Sclerosis Journal - October 2017 - 1524
Multiple Sclerosis Journal - October 2017 - 1525
Multiple Sclerosis Journal - October 2017 - 1526
Multiple Sclerosis Journal - October 2017 - 1527
Multiple Sclerosis Journal - October 2017 - 1528
Multiple Sclerosis Journal - October 2017 - 1529
Multiple Sclerosis Journal - October 2017 - 1530
Multiple Sclerosis Journal - October 2017 - 1531
Multiple Sclerosis Journal - October 2017 - 1532
Multiple Sclerosis Journal - October 2017 - 1533
Multiple Sclerosis Journal - October 2017 - 1534
Multiple Sclerosis Journal - October 2017 - 1535
Multiple Sclerosis Journal - October 2017 - 1536
Multiple Sclerosis Journal - October 2017 - 1537
Multiple Sclerosis Journal - October 2017 - 1538
Multiple Sclerosis Journal - October 2017 - 1539
Multiple Sclerosis Journal - October 2017 - 1540
Multiple Sclerosis Journal - October 2017 - 1541
Multiple Sclerosis Journal - October 2017 - 1542
Multiple Sclerosis Journal - October 2017 - 1543
Multiple Sclerosis Journal - October 2017 - 1544
Multiple Sclerosis Journal - October 2017 - 1545
Multiple Sclerosis Journal - October 2017 - 1546
Multiple Sclerosis Journal - October 2017 - 1547
Multiple Sclerosis Journal - October 2017 - 1548
Multiple Sclerosis Journal - October 2017 - 1549
Multiple Sclerosis Journal - October 2017 - 1550
Multiple Sclerosis Journal - October 2017 - 1551
Multiple Sclerosis Journal - October 2017 - 1552
Multiple Sclerosis Journal - October 2017 - 1553
Multiple Sclerosis Journal - October 2017 - 1554
Multiple Sclerosis Journal - October 2017 - 1555
Multiple Sclerosis Journal - October 2017 - 1556
Multiple Sclerosis Journal - October 2017 - 1557
Multiple Sclerosis Journal - October 2017 - 1558
Multiple Sclerosis Journal - October 2017 - 1559
Multiple Sclerosis Journal - October 2017 - 1560
Multiple Sclerosis Journal - October 2017 - 1561
Multiple Sclerosis Journal - October 2017 - 1562
Multiple Sclerosis Journal - October 2017 - 1563
Multiple Sclerosis Journal - October 2017 - 1564
Multiple Sclerosis Journal - October 2017 - 1565
Multiple Sclerosis Journal - October 2017 - 1566
Multiple Sclerosis Journal - October 2017 - Cover3
Multiple Sclerosis Journal - October 2017 - Cover4
https://www.nxtbookmedia.com